Back to Search Start Over

Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.

Authors :
Porter T
Burnham SC
Milicic L
Savage G
Maruff P
Lim YY
Ames D
Masters CL
Martins RN
Rainey-Smith S
Rowe CC
Salvado O
Groth D
Verdile G
Villemagne VL
Laws SM
Source :
Neurobiology of aging [Neurobiol Aging] 2019 Apr; Vol. 76, pp. 162-165. Date of Electronic Publication: 2019 Jan 06.
Publication Year :
2019

Abstract

The longevity gene Klotho (KL), specifically the functional KL-VS variant, has previously been associated with cognition and rates of cognitive decline. This study aimed to determine whether KL-VS associations with cognition were observable in preclinical Alzheimer's disease (AD). The study also aimed to determine whether there was a combined influence of KL-VS, neocortical amyloid-β (Aβ) burden, and carriage of the apolipoprotein E (APOE) ε4 allele on cognitive decline. This study involved 581 Aβ-imaged, cognitively normal older adults, enrolled in the Australian Imaging, Biomarkers and Lifestyle Study of Aging. Linear mixed effects models revealed no significant associations between KL-VS and cognitive decline independently or in combination with Aβ burden and APOE ε4 genotype. Overall, previous associations reported between KL-VS and cognitive decline are not observed at the preclinical stages of AD. Furthermore, the results do not support the hypothesis that KL-VS has a modifying effect on Aβ burden and APOE ε4-driven cognitive decline in preclinical AD.<br /> (Copyright © 2019 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1558-1497
Volume :
76
Database :
MEDLINE
Journal :
Neurobiology of aging
Publication Type :
Academic Journal
Accession number :
30716541
Full Text :
https://doi.org/10.1016/j.neurobiolaging.2018.12.014